Pattern of Isolated Fungi From Bronchoalveolar Lavage Among Patients With Lung Cancer
1 other identifier
observational
100
1 country
1
Brief Summary
The aim of the study is to assess the prevalence and pattern of isolated fungi from patients with lung cancer at the time of diagnosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2018
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2020
CompletedFirst Submitted
Initial submission to the registry
October 6, 2022
CompletedFirst Posted
Study publicly available on registry
October 12, 2022
CompletedOctober 12, 2022
October 1, 2022
2.6 years
October 6, 2022
October 10, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
number of participants with positive fungal growth
assessed by fungal culture of BAL
April 2018 and October 2020
Secondary Outcomes (1)
predictors of fungal infection in lung cancer participants
April 2018 and October 2020
Eligibility Criteria
All patients definitely diagnosed as central bronchogenic carcinoma
You may qualify if:
- All patients definitely diagnosed as central bronchogenic carcinoma from positive cytopathology of specimens taken through investigation by FOB before receiving any specific treatment.
You may not qualify if:
- the presence of neutropenia with an absolute neutrophil count \< 1,000/µL (equivalent to \< 1.0 × 109/L)
- patients on systemic corticosteroids therapy or those on chemotherapy or radiotherapy or antifungal treatment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Faculty of Medicine
Al Mansurah, 35516, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 6, 2022
First Posted
October 12, 2022
Study Start
March 1, 2018
Primary Completion
October 1, 2020
Study Completion
October 1, 2020
Last Updated
October 12, 2022
Record last verified: 2022-10